Mitochondrial Transplantation Therapy Ameliorates Muscular Dystrophy in <i>mdx</i> Mouse Model
Duchenne muscular dystrophy is caused by loss of the dystrophin protein. This pathology is accompanied by mitochondrial dysfunction contributing to muscle fiber instability. It is known that mitochondria-targeted in vivo therapy mitigates pathology and improves the quality of life of model animals....
Main Authors: | Mikhail V. Dubinin, Irina B. Mikheeva, Anastasia E. Stepanova, Anastasia D. Igoshkina, Alena A. Cherepanova, Alena A. Semenova, Vyacheslav A. Sharapov, Igor I. Kireev, Konstantin N. Belosludtsev |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/14/3/316 |
Similar Items
-
The Effect of Uridine on the State of Skeletal Muscles and the Functioning of Mitochondria in Duchenne Dystrophy
by: Mikhail V. Dubinin, et al.
Published: (2022-09-01) -
Effect of the Non-Immunosuppressive MPT Pore Inhibitor Alisporivir on the Functioning of Heart Mitochondria in Dystrophin-Deficient <i>mdx</i> Mice
by: Mikhail V. Dubinin, et al.
Published: (2021-09-01) -
Lipocalin 2 Influences Bone and Muscle Phenotype in the <i>MDX</i> Mouse Model of Duchenne Muscular Dystrophy
by: Marco Ponzetti, et al.
Published: (2022-01-01) -
The Effect of Deflazacort Treatment on the Functioning of Skeletal Muscle Mitochondria in Duchenne Muscular Dystrophy
by: Mikhail V. Dubinin, et al.
Published: (2020-11-01) -
A Novel Method for Detecting Duchenne Muscular Dystrophy in Blood Serum of <i>mdx</i> Mice
by: Nicole M. Ralbovsky, et al.
Published: (2022-07-01)